13.94
Overview
News
Price History
Option Chain
Why RDY Down?
Discussions
Forecast
Stock Split
Dividend History
Dr Reddys Laboratories Ltd Adr stock is traded at $13.94, with a volume of 1.30M.
It is down -1.97% in the last 24 hours and down -6.69% over the past month.
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
See More
Previous Close:
$14.22
Open:
$13.97
24h Volume:
1.30M
Relative Volume:
0.84
Market Cap:
$11.64B
Revenue:
$3.85B
Net Income/Loss:
$667.93M
P/E Ratio:
21.22
EPS:
0.657
Net Cash Flow:
$142.30M
1W Performance:
-4.98%
1M Performance:
-6.69%
6M Performance:
+0.87%
1Y Performance:
-15.55%
Dr Reddys Laboratories Ltd Adr Stock (RDY) Company Profile
Compare RDY with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
RDY
Dr Reddys Laboratories Ltd Adr
|
13.94 | 11.84B | 3.85B | 667.93M | 142.30M | 0.657 |
![]()
ZTS
Zoetis Inc
|
147.38 | 64.91B | 9.29B | 2.52B | 2.28B | 5.57 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.16 | 43.33B | 30.08B | 710.16M | 4.45B | 0.2182 |
![]()
HLN
Haleon Plc Adr
|
9.66 | 42.36B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.38 | 17.72B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
UTHR
United Therapeutics Corp
|
294.28 | 12.42B | 2.99B | 1.21B | 1.13B | 25.06 |
Dr Reddys Laboratories Ltd Adr Stock (RDY) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jun-05-25 | Upgrade | HSBC Securities | Hold → Buy |
Dec-19-24 | Downgrade | Nomura | Buy → Neutral |
Jan-11-24 | Downgrade | Jefferies | Buy → Underperform |
Aug-29-23 | Downgrade | HSBC Securities | Buy → Hold |
May-18-23 | Downgrade | Bernstein | Outperform → Mkt Perform |
Mar-17-23 | Upgrade | BofA Securities | Neutral → Buy |
Jan-30-23 | Initiated | JP Morgan | Underweight |
Nov-14-22 | Downgrade | Credit Suisse | Neutral → Underperform |
Jan-03-22 | Resumed | BofA Securities | Neutral |
Jul-27-21 | Downgrade | Credit Suisse | Outperform → Neutral |
Feb-02-21 | Upgrade | Barclays | Equal Weight → Overweight |
Sep-18-20 | Upgrade | BofA Securities | Neutral → Buy |
Sep-18-20 | Upgrade | Investec | Sell → Hold |
Jan-28-20 | Downgrade | CLSA | Buy → Outperform |
Jan-27-20 | Downgrade | CLSA | Buy → Outperform |
Jan-09-20 | Upgrade | Citigroup | Sell → Buy |
Nov-04-19 | Downgrade | BofA/Merrill | Buy → Neutral |
Sep-04-19 | Upgrade | Credit Suisse | Underperform → Outperform |
Jul-01-19 | Upgrade | Macquarie | Neutral → Outperform |
Jun-20-19 | Initiated | Deutsche Bank | Hold |
Jun-11-19 | Initiated | Barclays | Equal Weight |
May-20-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Feb-19-19 | Upgrade | CLSA | Outperform → Buy |
Jan-17-19 | Downgrade | Citigroup | Neutral → Sell |
Sep-21-17 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Aug-31-17 | Upgrade | CLSA | Underperform → Outperform |
Jul-28-17 | Downgrade | CLSA | Underperform → Sell |
Jul-27-16 | Downgrade | HSBC Securities | Hold → Reduce |
Jul-27-16 | Downgrade | Jefferies | Hold → Underperform |
Feb-10-16 | Upgrade | Credit Agricole | Underperform → Buy |
Nov-10-15 | Downgrade | Citigroup | Buy → Neutral |
View All
Dr Reddys Laboratories Ltd Adr Stock (RDY) Latest News
Asian ADRs Fall As Winners And Losers Stand Out - Finimize
Fibromyalgia Market Analysis Report 2025-2035 | Key Players Drive Competition in Expanding Treatment Options - GlobeNewswire Inc.
Trump Tariff Impact: Infosys, Wipro, HDFC Bank, Other ADR Shares Drop After US Levies 25% Tariff On India - MSN
Asian ADRs Falter On US Markets As Fintechs Slide - Finimize
NVO Stock Quote Price and Forecast - CNN
Asian Stocks Listed In The US Kicked Off The Week Lower - Finimize
Validea's Top Health Care Stocks Based On Peter Lynch7/28/2025 - Nasdaq
Asian Stocks Dipped As US-Listed ADRs Edged Lower - Finimize
Stock Picks Today: Infosys, Dr. Reddys Labs, Kajaria Ceramics, Tata Consumer Products On Brokerages Radar - NDTV Profit
Dr Reddy's Q1 Results Preview: Analysts Outlook Mixed, See Double-Digit Growth - MSN
Dr. Reddy’s Labs ADR earnings missed, revenue fell short of estimates - Investing.com Australia
India's Dr Reddy's says open to boosting U.S. manufacturing as tariff threat looms - sg.finance.yahoo.com
Dr Reddys Q1 Results Preview: Analysts Outlook Mixed, See Double-Digit Growth - NDTV Profit
Asian Stocks Mixed As S&P Asia 50 ADR Index Falls - Finimize
LLY Stock Quote Price and Forecast - CNN
HSBC Upgrades Dr. Reddy’s Laboratories Limited (RDY) to Buy from Hold - MSN
Asian ADRs Retreat As Mixed Results Hit The Market - Finimize
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
Morgan Stanley initiates coverage on Dr. Reddy’s stock with Equalweight rating - Investing.com India
Dr Reddy's Laboratories among four key stocks to trade ex-dividend today - Mint
Allspring Global Investments Holdings LLC Sells 439,622 Shares of Dr. Reddy’s Laboratories Ltd (NYSE:RDY) - Defense World
Dr. Reddys Labs, Diffusion Engineers, LMW Wheels India Dividends — Last Day To Buy - NDTV Profit
Trump Tariffs: Dr Reddys To Lupin — Pharma Stocks To Be In Focus After Threat Of 200% Levies - NDTV Profit
Mixed Movements In Asian Equities As Some Sectors Shine - Finimize
Full Truck Alliance Co. Ltd. Sponsored ADR (NYSE:YMM) Shares Acquired by Mirae Asset Global Investments Co. Ltd. - Defense World
Mather Group LLC. Buys 3,413 Shares of Haleon PLC Sponsored ADR (NYSE:HLN) - Defense World
Stock Traders Buy High Volume of VNET Group Call Options (NASDAQ:VNET) - Defense World
Dr. Reddy's Laboratories Ltd (NYSE:RDY) Stock Holdings Cut by Robeco Institutional Asset Management B.V. - MarketBeat
Asian Equities Traded in the US as ADRs Rise in Thursday Trading - 富途牛牛
Asian ADRs Climb With North And South Leaders - Finimize
Dr Reddy’s Breaks Past ₹1,330 Apex: SEBI RA Rajneesh Sharma Sees Trend Shift, Cautions Overbought Zone - Investing.com India
Dr Reddys Laboratories allots Equity shares - Business Standard
RDY’s Market Whiplash: 2.41% YTD Rise, 14.68% Rise in 30 Days - investchronicle.com
SBI Cards to WiproPrashanth Tapse suggests stocks to buy in the short term - Mint
Stocks Showing Rising Market Leadership: Dr. Reddy's Labs ADR Earns 81 RS Rating - Investor's Business Daily
Yatsen And Zai Lab Shine As Asian ADRs Climb In The US - Finimize
Dr. Reddy’s stock rises on biosimilar collaboration with Alvotech By Investing.com - Investing.com Nigeria
Dr. Reddy’s stock rises on biosimilar collaboration with Alvotech - Investing.com Australia
Dr Reddys Laboratories Ltd Adr Stock (RDY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):